About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Factorial Study of Metoprolol Succinate TOPROL-XL (324A)

Factorial Study of Metoprolol Succinate TOPROL-XL (324A)

NCT00642096·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

AstraZeneca

Age

18–80

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Diastolic blood pressure between 95 and 114 mm at screening and start of treatment

You may not be if

Significant conditions which in the opinion of the investigator place the subject at undue risk, eg Renal impairment, hepatitis
Known secondary causes of hypertension, eg, Cushing's syndrome, renal artery stenosis, pheochromocytoma, hyperaldosteronism
Systolic blood pressure greater or equal to 180 mm Hg at start of trial

The record

StatusCompleted

PhasePhase 3

Taking part1,900

StartedJun 2003

UpdatedMar 25, 2009

Conditions

High Blood Pressure (Hypertension).